Select Page

Older people newly prescribed sleeping pills like benzodiazepines and �Z-drugs� have over double the odds of a hip fracture in the first two weeks, scientists have found.

Experts have said there is a 53 per cent increase in risk for people taking the medication for more than two weeks.

Sleeping tablets are prescribed if people suffer severe insomnia or as a short term measure to ease symptoms of insomnia.

However, experts have warned of the dangers of the drugs as they can cause side effects – such as drowsiness the following morning, which can lead to falls.

Users can also become dependent on them.

NHS Choices said: �Doctors are usually reluctant to recommend sleeping tablets in the long-term because they just mask the symptoms without treating the underlying cause.�

The results come from a new study by researchers at Cardiff University and King�s College London.

�While �Z-drugs are fast becoming the doctor�s hypnotic prescription of choice, there is no evidence that they are a safer alternative to benzodiazepines in relation to hip fracture risk,� said Dr Ben Carter, Cardiff University�s School of Medicine and the Institute of Psychiatry, Psychology and Neuroscience, King�s College London.

�Our study shows that both appear to significantly increase the risk of hip fracture when newly prescribed by doctors.�

A study of people aged over 65 found that new users of these hypnotic medicines experienced nearly two and a half times the fracture rate, when compared with older people not taking hypnotics.

An estimated 53 per cent increase in fracture risk was identified in medium-term users  – 15 to 30 days, as well as a 20 per cent increased risk of hip fracture in long-term users  which scientists classed as greater than 30 days.

Dr Carter added: �Careful consideration of the immediate increased risk of hip fracture should inform the clinical decision-making process.

�Clinically effective measures like strength training to improve frailty, removal of hazards at home, visual correction and a medication review are also needed to mitigate the risk of hip fractures, particularly in the first few days of use.�

The research supports previous studies linking use of hypnotics by older people with an increased risk of accidents, dependence, cognitive decline and hip fracture.

The drugs are also thought to cause drowsiness, delayed reaction times and impaired balance.

The study, called Benzodiazepines, Z-drugs and the risk of hip fracture: A Systematic Review and Meta-Analysis has been published in the journal PLOS ONE.

Professional Scope of Practice *

The information herein on "Sleeping pills could DOUBLE risk of this dangerous fracture - are YOU at risk?" is not intended to replace a one-on-one relationship with a qualified health care professional, or licensed physician, and is not medical advice. We encourage you to make your own healthcare decisions based on your research and partnership with a qualified healthcare professional.

Blog Information & Scope Discussions

Our information scope is limited to Chiropractic, musculoskeletal, physical medicines, wellness, contributing etiological viscerosomatic disturbances within clinical presentations, associated somatovisceral reflex clinical dynamics, subluxation complexes, sensitive health issues, and/or functional medicine articles, topics, and discussions.

We provide and present clinical collaboration with specialists from a wide array of disciplines. Each specialist is governed by their professional scope of practice and their jurisdiction of licensure. We use functional health & wellness protocols to treat and support care for the injuries or disorders of the musculoskeletal system.

Our videos, posts, topics, subjects, and insights cover clinical matters, issues, and topics that relate to and support, directly or indirectly, our clinical scope of practice.*

Our office has reasonably attempted to provide supportive citations and identified the relevant research study or studies supporting our posts. We provide copies of supporting research studies available to regulatory boards and the public upon request.

We understand that we cover matters that require an additional explanation of how it may assist in a particular care plan or treatment protocol; therefore, to further discuss the subject matter above, please feel free to ask Dr. Alex Jimenez DC or contact us at 915-850-0900.

We are here to help you and your family.


Dr. Alex Jimenez DC, MSACP, CCST, IFMCP*, CIFM*, ATN*


Licensed in: Texas & New Mexico*

Dr. Alex Jimenez DC, MSACP, CIFM*, IFMCP*, ATN*, CCST
My Digital Business Card